Maria Cristina Mingari

Prof. Maria Cristina Mingari

Università degli Studi di Genova
+1

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2014 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
LMLorenzo Moretta
Lorenzo Moretta
GPGabriella Pietra
Gabriella Pietra
EMElisa Montaldo
Elisa Montaldo
PVPaola Vacca
Paola Vacca
Daniela PendeDaniela Pende
Daniela Pende
MMMaria Cristina Mingari
Maria Cristina Mingari
Natural Killer (NK) cells are major effector cells of the innate immunity. The discovery, over two decades ago, of MHC-class I specific NK receptors and subsequently of activating receptors, recognizing ligands expressed by tumor or virus-infected cells, paved the way to our understanding of the mechanisms of selective recognition and killing of tumor cells. Although NK cells can efficiently kill tumor cells of different histotypes in vitro, their activity may be limited in vivo by their inefficient trafficking to tumor lesions and by the inhibition of their function induced by tumor cells themselves and by the tumor microenvironment. On the other hand, the important role of NK cells has been clearly demonstrated in the therapy of high risk leukemias in the haploidentical hematopoietic cell (HSC) transplantation setting. NK cells derived from donor HSC kill leukemic cells residual after the conditioning regimen, thus preventing leukemia relapses. In addition, they also kill residual dendritic cells and T lymphocytes, thus preventing both GvHD and graft rejection.

1 April 2014 in Seminars in Immunology
Verified
Journal Article
Closed access
EMElisa Montaldo
Elisa Montaldo
PVPaola Vacca
Paola Vacca
LMLorenzo Moretta
Lorenzo Moretta
MMMaria Cristina Mingari
Maria Cristina Mingari

1 November 2016 in Immunology Letters
Verified
Journal Article
Closed access
EMElisa Montaldo
Elisa Montaldo
PVPaola Vacca
Paola Vacca
CVChiara Vitale
Chiara Vitale
FMFrancesca Moretta
Francesca Moretta
FLFranco Locatelli
Franco Locatelli
LMLorenzo Moretta
Lorenzo Moretta

3 February 2016 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
FMFrancesca Moretta
Francesca Moretta
FPFrancesca Petronelli
Francesca Petronelli
BLBarbarella Lucarelli
Barbarella Lucarelli
APAngela Pitisci
Angela Pitisci
ABAlice Bertaina
Alice Bertaina
EMElisa Montaldo
Elisa Montaldo
NK cells play a central role in the haploidentical HSC transplantation (HSCT) to cure high‐risk leukemias. Other innate lymphoid cells (ILCs) have been proposed to exert a protective role in graft‐versus‐host disease and could also contribute to anti‐microbial defence and to lymphoid tissue remodeling. Thus, we investigated the ILC differentiation potential of HSCs isolated from BM, mobilized peripheral blood (PB), and umbilical cord blood (UCB). BM CD34+ cells are enriched in lymphoid‐committed precursors, while PB CD34+ cells preferentially contain myeloid precursors. In vitro differentiation experiments revealed that the highest and the lowest CD56+CD161+ ILC recovery was detected in UCB and PB HSC cultures, respectively. Among CD56+CD161+ ILCs, the ratio between NK cells and ILC3s was similar for all HSC analyzed. ILC recovery in PB CD34+ cultures was lower for G‐CSF‐mobilized HSCs (good mobilizers) than for G‐CSF+plerixafor‐mobilized HSC (poor mobilizers). Moreover, G‐CSF inhibited in vitro ILC recovery and the degree of inhibition was proportional to the time of exposure to the cytokine. Thus, although all common sources of HSC for transplant differentiate towards ILCs, substantial differences exist among different sources and G‐CSF may influence ILC recovery. These data offer new clues for a better understanding of the immune reconstitution after HSCT.

1 February 2019 in Trends in Immunology
Verified
Journal Article
Closed access
MMMaria Cristina Mingari
Maria Cristina Mingari
GPGabriella Pietra
Gabriella Pietra
LMLorenzo Moretta
Lorenzo Moretta

1 December 2015 in Immunology Letters
Verified
Journal Article
Closed access
PVPaola Vacca
Paola Vacca
EMElisa Montaldo
Elisa Montaldo
CVChiara Vitale
Chiara Vitale
DCDaniele Croxatto
Daniele Croxatto
LMLorenzo Moretta
Lorenzo Moretta
MMMaria Cristina Mingari
Maria Cristina Mingari